Latest

19:24
[ China Longyuan Power (00916.HK): Completes Issuance of Three Tranches of Super Short-term Commercial Paper with Total Value of RMB 2.6 Billion ] NewTimeSpace News: China Longyuan Power announced on 16 July that the Company has recently completed the issuance of the 11th, 12th and 13th tranches of super short-term commercial paper for 2026, with a total issuance amount of RMB 2.6 billion and coupon rates of 1.49%, 1.37% and 1.37% respectively.
Tag： China Longyuan Power00916.HK
19:11
[ CLIFFORD MODERN LIVING HOLDINGS(03686.HK): Fair Value Loss on Precious Metals Investments ] NewTimeSpace News: CLIFFORD MODERN LIVING HOLDINGSannounced on 16 July that the Group expects to recognise disposal gains of approximately RMB 44.4 million and fair value losses of around RMB 82.1 million from its precious metals investments in the first half of 2026.
Tag： CLIFFORD MODERN LIVING HOLDINGS03686.HK
19:05
[ ENM HOLDINGS(00128.HK): Profit Warning, Interim Loss Expected at Approximately HK$8.7 Million ] NewTimeSpace News: ENM HOLDINGSannounced on 16 July that the Group expects to record a loss attributable to shareholders of approximately HK$8.7 million for the six months ended 30 June 2026, compared with a profit of HK$9.7 million for the same period last year.
Tag： ENM HOLDINGS00128.HK
18:48
[ Qunabox Group Limited (00917.HK): Non-executive Director Dai Jianchun Resigns ] NewTimeSpace News: Qunabox Group announced on 16 July that Mr. Dai Jianchun, Non-executive Director, tendered his resignation as Non-executive Director with effect from 16 July.
Tag： Qunabox Group Limited00917.HK
18:36
[ Greatview Aseptic Packaging (00468.HK): Profit Warning, Interim Net Profit Expected to Slump 87.7% to 95.9% ] NewTimeSpace News: Greatview Aseptic Packaging announced on 16 July that the Group expects its revenue for the six months ended 30 June 2026 to range from approximately RMB 732 million to RMB 990 million, representing a year-on-year decline of roughly 1.6% to 27.3%; net profit is projected at RMB 3.4 million to RMB 10.2 million, a year-on-year drop of about 87.7% to 95.9%.
Tag： Greatview Aseptic Packaging00468.HK
18:30
[ WellCell Holdings(02477.HK): Placing and Top-up Subscription Completed, Net Proceeds of Approximately HK$188 Million Raised ] NewTimeSpace News: WellCell Holdingsannounced on 16 July that the placing agent has placed a total of 796 million placing shares at HK$0.24 per share. The Company allotted and issued the same number of subscription shares to the vendor concurrently, generating net proceeds of roughly HK$188 million.
Tag： WellCell Holdings02477.HK
18:23
[ Chu Kong Shipping Enterprises (00560.HK): Positive Profit Forecast, Interim Profit Expected to Rise 30% to 45% ] NewTimeSpace News: Chu Kong Shipping Enterprises announced on 16 July that the Group expects its unaudited consolidated profit attributable to shareholders for the six months ended 30 June 2026 to range from approximately HK$34.6 million to HK$38.6 million, representing a year-on-year increase of around 30% to 45% compared with HK$26.6 million recorded in the same period last year.
Tag： Chu Kong Shipping Enterprises00560.HK
18:19
[ Harbin Bank (06138.HK): Director Du Xiaoquan’s Qualification Approved ] NewTimeSpace News: Harbin Bank announced on 16 July that the qualification of Mr. Du Xiaoquan to serve as the Company’s Non-executive Director has been approved by the Heilongjiang Regulatory Bureau of the State Administration of Financial Supervision, with effect from 14 July.
Tag： Harbin Bank06138.HK
18:15
[ Hengrui Pharmaceuticals(01276.HK): Injection HRS9531 Obtains Clinical Trial Approval Notice ] NewTimeSpace News: Hengrui Pharmaceuticalsannounced on 16 July that its subsidiary Fujian Shengdi has received the Clinical Trial Approval Notice for Injection HRS9531 issued by the National Medical Products Administration (NMPA).
Tag： Hengrui Pharmaceuticals01276.HK
17:50
[ BONJOUR HOLD(00653.HK) closed 22% higher on Jul 16, leading the gains in the Hang Seng Specialty Retail Sector ] By the close of trading on Jul 16, 2026, BONJOUR HOLD(00653.HK) saw a gain of 22% in its share price, closing at HK cents 6.1. During the session, it reached an intraday high of HK cents 6.3 and touched an intraday low of HK cents 4.9.
Tag： BONJOUR HOLD00653.HK
17:44
[ JOLIMARK(02028.HK) closed 29.41% lower on Jul 16, the Hang Seng IT Hardware Sector saw divergent trends ] NewTimeSpace (newtimespace.com) News, By the close of trading on Jul 16, 2026, JOLIMARK(02028.HK) saw a loss of 29.41% in its share price, closing at HKD 1.8. During the session, it reached an intraday high of HKD 2.61 and touched an intraday low of HKD 1.69.
Tag： JOLIMARK02028.HKNewTimeSpace
17:17
[ GHPC (01847.HK): Appoints Wang Junjie as Chief Engineer, Term Expiring Upon Completion of the Third Board of Directors ] NewTimeSpace News: GHPC (01847.HK) announced on 16 July that Mr. Wang Junjie has been appointed Chief Engineer of the Company with tenure running until the expiry of the term of the third Board of Directors. A 40-year-old senior engineer, Mr. Wang joined the Group in 2017, has received multiple technical honours and holds three invention patents.
Tag： GHPC01847.HKChief Engineer
16:48
[ INNOCARE (09969.HK): TYK2 Inhibitor Soficitinib (ICP-332) Meets Primary Endpoint in Phase II for Non-Segmental Vitiligo, 24-Week F-VASI Reduced by Around 39%-41% vs Baseline ] NewTimeSpace News: INNOCARE (09969.HK) announced on 16 July that its TYK2 inhibitor Soficitinib (ICP-332) hit the primary endpoint in the Phase II segment of adaptive Phase II/III trial for adult patients with non-segmental vitiligo. F-VASI dropped roughly 39%-41% at Week 24 versus baseline, versus only 2.2% in placebo arm with statistically significant differences. The candidate demonstrated favourable safety profile, and the Company will advance to Phase III and communicate with regulators. Risks associated with clinical development exist.
Tag： INNOCARE09969.HKClinical Trial
16:41
[ HENLIUS (02696.HK): Biosimilar HLX18 to Nivolumab Doses First Patient in China for Global Multi-centre Phase I Trial ] NewTimeSpace News: Henlius (02696.HK) announced on 16 July that HLX18, its self-developed biosimilar of nivolumab (recombinant anti-PD-1 humanised monoclonal antibody injection), has administered the first patient in China in its global multi-centre Phase I trial for resected solid tumours. The Company plans to expand the trial to the US and other regions when conditions permit. Targeting PD-1, the reference drug recorded global sales of approximately USD11.785 billion in 2025 per IQVIA data. The Company cautions there is no guarantee of successful development and commercialisation of HLX18.
Tag： HENLIUS02696.HKClinical Trial
16:36
[ BIDU-SW (09888.HK): Proposes Voluntary Conversion to Dual Primary Listing on HKEX Main Board ] NewTimeSpace News: BIDU-SW (09888.HK) announced that the Board of Directors has approved a proposal to voluntarily convert its listing status to dual primary listing on the HKEX Main Board in accordance with HKEX guidance letters, with conversion expected to take effect within the current year. Upon completion, Baidu will be dual-primary listed on HKEX Main Board and Nasdaq Global Select Market.
Tag： BIDU-SW09888.HKdual-primary listing
16:05
[ Autonomous Driving Concept Stocks Watch | BIDU-SW(09888.HK) Trades Stronger; Apollo Go Accumulates Over 22 Million Service Orders as of April ] NewTimeSpace News: On 16 July 2026, BIDU-SW(09888.HK) strengthened in the afternoon session. As of 15:44, its intraday price stood at HK$110.10, representing a 2.42% gain. Baidu’s Apollo Go has fulfilled more than 22 million cumulative service orders as of April, with its business footprint covering 27 cities worldwide.
Tag： BIDU-SW09888.HKAutonomous Driving
15:41
[ CSOP FTSE China A50 ETF (02822.HK) Fell 2.25% Intraday, AUM at HKD 7.318 Billion ] NewTimeSpace News: As of 15:35 on July 16, CSOP FTSE China A50 ETF (02822.HK) dropped 2.25%, with the latest price at HKD 15.640.
Tag： CSOP FTSE China A50 ETFETF02822.HK
15:26
[ Bosera Szse Chinext Daily (2x) Leveraged Product (07234.HK) Fell 5.72% Intraday, Turnover at HKD 22.6718 Million ] NewTimeSpace News: As of 15:21 on July 16, Bosera Szse Chinext Daily (2x) Leveraged Product (07234.HK) dropped 5.72%, with the latest price at HKD 10.550.
Tag： ETFBosera Szse Chinext Daily (2x) Leveraged Product07234.HK
15:22
[ Chinaamc CSI 300 Index ETF (03188.HK) Fell 2.01% Intraday, AUM at HKD 18.988 Billion ] NewTimeSpace News: As of 15:16 on July 16, Chinaamc CSI 300 Index ETF (03188.HK) dropped 2.01%, with the latest price at HKD 56.680.
Tag： Chinaamc CSI 300 Index ETFETF03188.HK
15:10
[ CSOP YINHUA CSI 5G COMMUNICATIONS THEME ETF (03193.HK) Fell 3.63% Intraday, Turnover at HKD 1.98 Million ] NewTimeSpace News: As of 15:08 on July 16, CSOP YINHUA CSI 5G COMMUNICATIONS THEME ETF (03193.HK) dropped 3.63%, with the latest price at HKD 19.660.
Tag： CSOP YINHUA CSI 5G COMMUNICATIONS THEME ETFETF03193.HK
Previous1..281282 283284285..580     580 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments